Clinical Trial: TAVR vs SAVR in Severe Bicuspid Aortic Stenosis

U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07413965) titled 'TAVR vs SAVR in Severe Bicuspid Aortic Stenosis' on Jan. 30.

Brief Summary: The study is a multicenter, randomized superiority trial of standard of care therapies for severe aortic stenosis (AS) in patients with a bicuspid aortic valve (BAV).

The two primary comparators in this study are: Transcatheter Aortic Valve Replacement (TAVR), and Surgical Aortic Valve Replacement (SAVR).

TAVR is a minimally invasive transcatheter procedure to treat aortic valve disease..

SAVR is involving the open chest surgery to replace the aortic valve.

The devices and international procedures in this Trial (TAVR or SAVR) are commercially approved by...